BioAge Labs, Inc. (BIOA)
5.87
-0.07
(-1.18%)
USD |
NASDAQ |
Oct 30, 16:00
5.90
+0.03
(+0.51%)
After-Hours: 20:00
BioAge Labs Price : 5.87 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 5.87 | 5.925 | 5.63 | 5.87 | 801359.0 |
| Oct 29, 2026 | 5.95 | 6.255 | 5.82 | 5.94 | 845254.0 |
| Oct 28, 2026 | 5.41 | 5.97 | 5.22 | 5.94 | 1.436M |
| Oct 27, 2026 | 4.98 | 5.51 | 4.92 | 5.47 | 1.111M |
| Oct 26, 2026 | 5.10 | 5.15 | 4.92 | 4.99 | 539015.0 |
| Oct 23, 2026 | 5.48 | 5.48 | 5.05 | 5.10 | 465874.0 |
| Oct 22, 2026 | 5.45 | 5.62 | 5.411 | 5.53 | 482316.0 |
| Oct 21, 2026 | 5.61 | 5.70 | 5.43 | 5.51 | 568546.0 |
| Oct 20, 2026 | 5.00 | 5.64 | 4.97 | 5.56 | 1.205M |
| Oct 19, 2026 | 4.84 | 5.11 | 4.82 | 4.99 | 1.245M |
| Oct 16, 2026 | 5.35 | 5.35 | 4.81 | 4.84 | 868261.0 |
| Oct 15, 2026 | 5.48 | 5.50 | 5.28 | 5.35 | 811332.0 |
| Oct 14, 2026 | 5.49 | 5.58 | 5.36 | 5.42 | 614890.0 |
| Oct 13, 2026 | 5.90 | 5.90 | 5.54 | 5.57 | 638502.0 |
| Oct 12, 2026 | 6.24 | 6.295 | 5.875 | 5.94 | 482158.0 |
| Oct 09, 2026 | 6.21 | 6.47 | 6.145 | 6.34 | 667340.0 |
| Oct 08, 2026 | 6.17 | 6.265 | 5.99 | 6.21 | 906857.0 |
| Oct 07, 2026 | 6.23 | 6.675 | 6.17 | 6.26 | 799969.0 |
| Oct 06, 2026 | 6.44 | 6.45 | 6.00 | 6.29 | 3.252M |
| Oct 05, 2026 | 6.65 | 6.65 | 6.25 | 6.36 | 783353.0 |
| Oct 02, 2026 | 6.92 | 6.92 | 6.47 | 6.61 | 869990.0 |
| Oct 01, 2026 | 7.06 | 7.17 | 6.70 | 6.81 | 591113.0 |
| Sep 30, 2026 | 7.20 | 7.26 | 6.97 | 7.09 | 755933.0 |
| Sep 29, 2026 | 7.19 | 7.27 | 7.07 | 7.14 | 425329.0 |
| Sep 28, 2026 | 7.11 | 7.425 | 6.96 | 7.18 | 800189.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Neumora Therapeutics, Inc. | 0.3672 |
| Alumis, Inc. | 6.73 |
| ANI Pharmaceuticals, Inc. | 72.00 |
| Corcept Therapeutics, Inc. | 81.12 |
| Veru, Inc. | 2.19 |
Price Related Metrics
| PS Ratio | 22.57 |
| PEG Ratio | -0.3644 |
| Price to Book Value | 0.7167 |
| Earnings Yield | -40.66% |
| Market Cap | 268.71M |
| PEGY Ratio | -0.3644 |